• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Ophthalmologic procedures are not associated with increased risk for acute myocardial infarction

byDavid XiangandHarsh Shah
April 22, 2022
in Cardiology, Chronic Disease, Ophthalmology
Reading Time: 2 mins read
Nonpowder gun-related pediatric eye injuries on the rise
Share on FacebookShare on Twitter

1. Based on the study, there was no evidence of increased risk for acute myocardial infarction after an ophthalmologic procedure.

2. Outpatient ophthalmologic procedures, even when stratified on type of surgery and anesthesia, were not associated with an increased risk for acute myocardial infarction.

Evidence Rating Level: 2 (Good)

Study Rundown: Invasive surgical procedures represent physiological stressors for patients and can cause inflammation as well as immobility, which increases the risk of plaque rupture, increased platelet aggregability, and decreased fibrinolysis that can precipitate an acute myocardial infarction (AMI). Ophthalmologic procedures, done in outpatient settings, are generally less invasive, yet previous cohort studies have suggested temporal associations between ophthalmologic procedures and AMI. However, they were not designed to study the effects of transient exposures. Therefore, there is a gap in knowledge as to understanding whether ambulatory ophthalmologic procedures lead to the increased onset of AMI. This study found that ophthalmologic procedures done in an outpatient setting were not associated with an increased risk for AMI. This study was limited by factors such as potential bias from time-varying confounders between the hazard and control periods. Nevertheless, these study’s findings are significant, as they demonstrate that outpatient ophthalmologic procedures are not associated with a higher risk for AMI, and seem to be safe in general.

Click to read the study in AIM

Relevant Reading: Summary for Patients: Risk for Heart Attack After Eye Procedures

RELATED REPORTS

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

A novel score is effective at identifying non-ST-segment elevation acute coronary syndrome patients with totally occluded infarct-related artery

In-Depth [case-crossover study]: This case-crossover study utilized a population-based nationwide study from Norway and Sweden, with patients receiving outpatient ophthalmologic procedures in Norway from 2008 to 2014 or in Sweden from 2001 to 2014. Patients who were 40 years or older, with a primary diagnosis of ICD codes I21 or I22 between March 2008 and December 2016 in Norway, or between March 2001 and December 2014 in Sweden were eligible for the study. Patients who received ophthalmologic procedures outside of this time frame were excluded from the study. The primary outcome measured was exposure to ophthalmologic procedures in the 0 to 7 days before AMI diagnosis, compared with an 8-day period 30 days earlier before AMI (control week), to estimate the relative risk for an AMI the week after an ophthalmologic procedure. Outcomes in the primary analysis were assessed via conditional logistic regression. Based on the analysis, there was a lower risk of AMI in the week after an ophthalmologic procedure than during the control week (Odds Ratio 0.83, 95% Confidence Interval, 0.75 to 0.91). There was also no evidence of increased risk for AMI even when patients were stratified by surgery subtype, type of anesthesia, duration, invasiveness (low, intermediate, or high), age, or preexisting comorbidities. Overall, this study demonstrated that ophthalmologic procedures are not associated with an increased risk of AMI, and show that these outpatient procedures are generally safe, though preventive strategies to decrease excess risk should still be taken.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: acute myocardial infarctionmyocardial infarctionNorwayophthalmologic procedureSweden
Previous Post

Prenatal medication for opioid use disorder helps discharge infants back to mothers

Next Post

Vaccination leads to a small absolute risk for shoulder conditions

RelatedReports

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

January 12, 2026
Lariat device for left atrial appendage exclusion associated with adverse events
Cardiology

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

January 13, 2026
PCI not superior to medical therapy alone in stable coronary disease: The COURAGE study
Cardiology

A novel score is effective at identifying non-ST-segment elevation acute coronary syndrome patients with totally occluded infarct-related artery

January 13, 2026
Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

Use of ticagrelor may provide improved myocardial protection compared to clopidogrel in pharmaco-invasive ST-segment elevation myocardial infarction

January 13, 2026
Next Post
Medical vaccine exemptions increase after elimination of nonmedical exemptions

Vaccination leads to a small absolute risk for shoulder conditions

Patient Basics: Hair Loss

Baricitinib is superior to placebo for treatment of alopecia areata

RTS,SA/S01 anti-malarial vaccine efficacy wanes significantly over time

Higher-dose primaquine has higher efficacy in preventing relapse of Plasmodium vivax malaria

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Video mental health care may have clinical advantages versus phone or in-person visits
  • Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.